Therapeutic incompatibilities: drug interactions.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D004285:Dogs; D004336:Drug Antagonism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007004:Hypoglycemic Agents / Q000009:adverse effects; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D009132:Muscles / Q000009:adverse effects; D010634:Phenobarbital / Q000009:adverse effects; D011817:Rabbits; D051381:Rats; D011955:Receptors, Drug; D014149:Tranquilizing Agents / Q000009:adverse effects; D014556:Urine
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D007004:Hypoglycemic Agents; D008996:Monoamine Oxidase Inhibitors; D011955:Receptors, Drug; D014149:Tranquilizing Agents; D010634:Phenobarbital